https://www.marketwatch.com/story/trillium-therapeutics-stock-nearly-triples-after-buyout-deal-with-pfizer-valued-at-226-billion-2021-08-23
Shares of Trillium Therapeutics Inc. undefined nearly tripled in premarket trading Monday, skyrocketing 189.3%, after the immuno-oncology company announced...
Create an account or login to join the discussion